KYMERA THERAPEUTICS - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
88985233
Word Mark
KYMERA THERAPEUTICS
Status
748 - Statement Of Use - To Examiner
Status Date
2023-07-31
Filing Date
2018-11-22
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-10-08
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
DEFORD, JEFFREY S
Statements
Disclaimer with Predetermined Text
"THERAPEUTICS"
Goods and Services
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-12-12
Primary Code
042
First Use Anywhere Date
2017-10-31
First Use In Commerce Date
2017-10-31
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
GLENN A GUNDERSEN
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Parent | 88203328 |
Trademark Events
Event Date | Event Description |
2018-11-26 | NEW APPLICATION ENTERED |
2018-12-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
2019-02-25 | ASSIGNED TO EXAMINER |
2019-02-26 | NON-FINAL ACTION WRITTEN |
2019-02-26 | NON-FINAL ACTION E-MAILED |
2019-02-26 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-08-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-08-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-08-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-09-03 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-09-05 | ASSIGNED TO LIE |
2019-09-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-10-08 | PUBLISHED FOR OPPOSITION |
2019-10-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-11-07 | OPPOSITION PAPERS RECEIVED AT TTAB |
2019-11-14 | OPPOSITION INSTITUTED NO. 999999 |
2020-11-02 | OPPOSITION DISMISSED NO. 999999 |
2020-12-03 | OPPOSITION TERMINATED NO. 999999 |
2020-12-03 | TTAB RELEASE CASE TO TRADEMARKS |
2021-01-12 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-07-12 | TEAS EXTENSION RECEIVED |
2021-07-12 | SOU EXTENSION 1 FILED |
2021-07-12 | SOU EXTENSION 1 GRANTED |
2021-07-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-01-11 | TEAS EXTENSION RECEIVED |
2022-01-11 | SOU EXTENSION 2 FILED |
2022-01-11 | SOU EXTENSION 2 GRANTED |
2022-01-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2022-07-12 | TEAS EXTENSION RECEIVED |
2022-07-12 | SOU EXTENSION 3 FILED |
2022-07-12 | SOU EXTENSION 3 GRANTED |
2022-07-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2023-01-11 | TEAS EXTENSION RECEIVED |
2023-01-11 | SOU EXTENSION 4 FILED |
2023-01-11 | SOU EXTENSION 4 GRANTED |
2023-01-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2023-07-31 | TEAS STATEMENT OF USE RECEIVED |
2023-07-10 | TEAS REQUEST TO DIVIDE RECEIVED |
2023-07-31 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2023-07-07 | DIVISIONAL REQUEST RECEIVED |
2023-07-31 | DIVISIONAL PROCESSING COMPLETE |
2023-07-10 | USE AMENDMENT FILED |
2023-07-31 | STATEMENT OF USE PROCESSING COMPLETE |